quinoxalines has been researched along with estradiol 3-benzoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bereiter, DA; Okamoto, K; Tashiro, A | 1 |
| Bean, LA; Cruz, PE; Foster, TC; Golde, TE; Guidi, M; Kumar, A; Rani, A; Rosario, AM | 1 |
2 other study(ies) available for quinoxalines and estradiol 3-benzoate
| Article | Year |
|---|---|
NMDA receptor blockade reduces temporomandibular joint-evoked activity of trigeminal subnucleus caudalis neurons in an estrogen-dependent manner.
Topics: 2-Amino-5-phosphonovalerate; Adenosine Triphosphate; Animals; Estradiol; Estrogens; Female; Neurons; Ovariectomy; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Temporomandibular Joint; Trigeminal Caudal Nucleus | 2009 |
Re-Opening the Critical Window for Estrogen Therapy.
Topics: Animals; Contraceptive Agents; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Gene Expression Regulation; HEK293 Cells; Hippocampus; Humans; Learning Disabilities; Maze Learning; Nerve Tissue Proteins; Ovariectomy; Quinoxalines; Rats; Rats, Inbred F344; Spatial Memory; Time Factors; Transduction, Genetic | 2015 |